Nautilus Biotechnolgy's total assets for Q4 2023 were $305.56M, an increase of 82.23% from the previous quarter. NAUT total liabilities were $40.21M for the fiscal quarter, a -66.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.